Preclinical evidence shows that enhancing LPL activity improves triglyceride clearance and lipid profile modulation, underscoring its therapeutic potential in hyperlipidemia (Goldberg and Merkel, 2001). The gene discussed is LPL; the disease is hyperlipidemia.